week 17 check-in — 4kg down, fatigue manageable, one thing confusing me

Here it is: week 17 check-in — 4kg down, fatigue manageable, one thing confusing me. One person, one log, no control group, so read it accordingly.

Hard numbers: week 17 and 4kg. Anything softer than that is flagged as an impression.

Reading the trial literature on this without misleading yourself.

Separate the monotherapy arms from the combination arms before you do anything else. They report different effect sizes and different tolerability, and almost every summary that circulates blends them.

Then read the tolerability tables rather than the headline. In combination work the interesting question is whether adding a second mechanism adds effect without adding proportionate side effects, and that question is answered in a table nobody quotes.

Finally, note the durations. Comparing a shorter readout here with a longer one from an established compound is not a comparison at all.

The honest state of the evidence on this board, since somebody should write it down.

Published clinical data exists and is genuinely interesting, particularly in combination. Independent purity data from members is thin — a handful of results across the whole site, against hundreds for the older molecules. Nothing containing this compound is approved as a standalone product, and research-use-only material is not approved for human use.

What follows practically: buy small if you buy at all, test what you get and post the result, and treat confident rankings against established compounds as the extrapolation they are. The board gets better as the log fills, and right now the log is nearly empty.

If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.